CompuMed, Inc.
CMPD · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6.6% | -8.3% | 0.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 48.6% | 49.4% | 51.9% | 53% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 15.3% | 11.8% | 17.6% | 23.4% |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 3.1% | -0.6% | 7.9% | 16.9% |
| EPS Diluted | 0.15 | -0.021 | 0.3 | 0.69 |
| % Growth | 817.7% | -107% | -56.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |